Carina Rodrigues Boeck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carina Rodrigues Boeck has a total of 270 co-authors. Here are the top co-authors by number of shared publications:
- Carla I. Tasca
Laboratório de Neuroquímica-4 (LabNeQ4), Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil
10 shared publications - João Quevedo
Center for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, USA
9 shared publications Deusa Vendite
7 shared publications- Elaine Cristina Gavioli
Universidade Federal do Rio Grande do Norte
7 shared publications - Bruno Herculano
Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
5 shared publications - Felipe Dal-Pizzol
Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, University of Southern Santa Catarina, Criciúma, SC, Brazil
5 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
Purinergic Imbalance and Adenosinergic Modulation of Antibacterial Activity in Severe COVID-19 and Sepsis
Sepsis and immunosuppression are major contributors to mortality in the intensive care unit. This study investigated dysregulated purinergic signaling, particularly systemic adenosine alterations, in relation to biomarkers and impaired antibacterial activity in severe COVID-19 and sepsis. Peripheral blood samples from COVID-19 patients at different disease stages were analyzed. Plasma purine levels were quantified by LC-MS/MS. To assess the functional effects of patient plasma, PBMCs from healthy donors were incubated with plasma from severe COVID-19 patients, resulting in increased CD39, PD-1, and KLRG1 and reduced CD73, CD28, and CD127 expression on T cells. Antibacterial activity was assessed in vitro using healthy-donor monocytes and RAW 264.7 macrophages exposed to patient plasma and challenged with GFP-expressing Escherichia coli (OP50-GFP). At hospital admission, ATP was lower, and AMP was higher in SARS-CoV-2-negative pneumonia and non-ICU and ICU COVID-19 patients than in healthy controls, whereas adenosine was lower in both COVID-19 groups. Longitudinally, nonsurvivors showed decreased ATP and increased adenosine from T1 to T2, with higher Δadenosine and lower ΔATP than survivors. Among septic patients, adenosine was higher in nonsurvivors. In vitro, cells exposed to plasma from septic ICU patients exhibited lower antibacterial activity. Adenosine and the A1/A2A antagonists DPCPX and ZM 241385 further supported a role for adenosinergic signaling: adenosine alone or combined with DPCPX reduced antibacterial activity, whereas DPCPX alone increased it. Overall, dysregulated purinergic signaling, particularly altered adenosine dynamics, may contribute to impaired antibacterial defense and immune dysfunction in severe COVID-19, with circulating plasma factors potentially increasing susceptibility to secondary infections.
- 17 November 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
Open AccessPurinergic Imbalance and Adenosinergic Modulation of Antibacterial Activity in Severe COVID-19 and Sepsis
Sepsis and immunosuppression are major contributors to mortality in the intensive care unit. This study investigated dysregulated purinergic signaling, particularly systemic adenosine alterations, in relation to biomarkers and impaired antibacterial activity in severe COVID-19 and sepsis. Peripheral blood samples from COVID-19 patients at different disease stages were analyzed. Plasma purine levels were quantified by LC-MS/MS. To assess the functional effects of patient plasma, PBMCs from healthy donors were incubated with plasma from severe COVID-19 patients, resulting in increased CD39, PD-1, and KLRG1 and reduced CD73, CD28, and CD127 expression on T cells. Antibacterial activity was assessed in vitro using healthy-donor monocytes and RAW 264.7 macrophages exposed to patient plasma and challenged with GFP-expressing Escherichia coli (OP50-GFP). At hospital admission, ATP was lower, and AMP was higher in SARS-CoV-2-negative pneumonia and non-ICU and ICU COVID-19 patients than in healthy controls, whereas adenosine was lower in both COVID-19 groups. Longitudinally, nonsurvivors showed decreased ATP and increased adenosine from T1 to T2, with higher Δadenosine and lower ΔATP than survivors. Among septic patients, adenosine was higher in nonsurvivors. In vitro, cells exposed to plasma from septic ICU patients exhibited lower antibacterial activity. Adenosine and the A1/A2A antagonists DPCPX and ZM 241385 further supported a role for adenosinergic signaling: adenosine alone or combined with DPCPX reduced antibacterial activity, whereas DPCPX alone increased it. Overall, dysregulated purinergic signaling, particularly altered adenosine dynamics, may contribute to impaired antibacterial defense and immune dysfunction in severe COVID-19, with circulating plasma factors potentially increasing susceptibility to secondary infections.
- Open Access
- 9 June 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 266, 174228
Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study
- 9 June 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 266, 174228
Open AccessImprovement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study
- Open Access
- 14 January 2026
- Published by Universidade Federal do Estado do Rio de Janeiro UNIRIO in Revista de Pesquisa Cuidado é Fundamental Online
- Vol. 18
Contribution of awareness/training workshops to the knowledge of health professionals about palliative care / Contribuição de oficinas de sensibilização/capacitação para o conhecimento de profissionais da saúde sobre os cuidados paliativos
Objetivo: analisar o conhecimento da equipe multiprofissional de saúde de um hospital sobre os Cuidados Paliativos antes e após oficina de sensibilização. Método: pesquisa-ação estratégica, desenvolvida com 16 profissionais de saúde de uma Instituição Hospitalar do Rio Grande do Sul, Brasil. Os dados coletados em agosto e setembro de 2024, mediante entrevista semiestruturada, antes e após uma oficina de sensibilização, foram submetidos à análise textual discursiva. Resultados: antes das oficinas evidenciou-se o (Des)conhecimento sobre os Cuidados Paliativos; (Des)conhecimento da atuação multiprofissional em Cuidados Paliativos; (Des)conhecimento sobre a diferenciação dos Métodos tradicionais e Cuidados Paliativos. Após as oficinas, identificou-se uma compreensão mais aprofundada sobre o assunto, bem como uma percepção favorável acerca da criação do Serviço Multiprofissional em Cuidados Paliativos. Conclusão: ampliou-se o conhecimento sobre a temática, a partir da oficina de sensibilização.
- 14 January 2026
- Published by Universidade Federal do Estado do Rio de Janeiro UNIRIO in Revista de Pesquisa Cuidado é Fundamental Online
- Vol. 18
Open AccessContribution of awareness/training workshops to the knowledge of health professionals about palliative care / Contribuição de oficinas de sensibilização/capacitação para o conhecimento de profissionais da saúde sobre os cuidados paliativos
Objetivo: analisar o conhecimento da equipe multiprofissional de saúde de um hospital sobre os Cuidados Paliativos antes e após oficina de sensibilização. Método: pesquisa-ação estratégica, desenvolvida com 16 profissionais de saúde de uma Instituição Hospitalar do Rio Grande do Sul, Brasil. Os dados coletados em agosto e setembro de 2024, mediante entrevista semiestruturada, antes e após uma oficina de sensibilização, foram submetidos à análise textual discursiva. Resultados: antes das oficinas evidenciou-se o (Des)conhecimento sobre os Cuidados Paliativos; (Des)conhecimento da atuação multiprofissional em Cuidados Paliativos; (Des)conhecimento sobre a diferenciação dos Métodos tradicionais e Cuidados Paliativos. Após as oficinas, identificou-se uma compreensão mais aprofundada sobre o assunto, bem como uma percepção favorável acerca da criação do Serviço Multiprofissional em Cuidados Paliativos. Conclusão: ampliou-se o conhecimento sobre a temática, a partir da oficina de sensibilização.
- 15 October 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Nanostructured delivery of lavandula essential oils improves safety and neuroprotective efficacy in vivo
- 15 October 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Nanostructured delivery of lavandula essential oils improves safety and neuroprotective efficacy in vivo
- Open Access
- 30 April 2025
- Published by Centro Universitario La Salle - UNILASALLE in Saúde e Desenvolvimento Humano
- Vol. 13 (1)
Neurobiologia do Transtorno de Déficit de Atenção e Hiperatividade
Introdução: o transtorno de Déficit de Atenção e Hiperatividade (TDAH) é caracterizado por padrões persistentes de desatenção, hiperatividade e impulsividade, o que afeta o funcionamento pessoal e social de seus portadores. O TDAH apresenta múltiplos fatores associados a sua fisiopatologia, sem haver, até então, uma causa exclusiva. Objetivos: o objetivo deste trabalho é analisar as interações gene-ambiente e mecanismos neurobiológicos envolvidos na etiologia do TDAH, a fim de contribuir para uma melhor compreensão do transtorno. Metodologia: foram realizadas pesquisas em bases de dados como MedLine, Pubmed e Scielo, com o uso dos descritores; Attention Deficit Hyperactivity Disorder; ADHD; neurobiology of ADHD. Resultados: os estudos revisados destacaram alterações morfofuncionais de regiões cerebrais específicas, quando em associação ao TDAH. Além disso, a combinação de diferentes fatores genéticos e ambientais podem influenciar no desenvolvimento do transtorno. Conclusões: a compreensão aprofundada da neurobiologia do TDAH é essencial para o desenvolvimento de intervenções mais eficazes, a fim de melhorar a qualidade de vida dos portadores do transtorno.
- 30 April 2025
- Published by Centro Universitario La Salle - UNILASALLE in Saúde e Desenvolvimento Humano
- Vol. 13 (1)
Open AccessNeurobiologia do Transtorno de Déficit de Atenção e Hiperatividade
Introdução: o transtorno de Déficit de Atenção e Hiperatividade (TDAH) é caracterizado por padrões persistentes de desatenção, hiperatividade e impulsividade, o que afeta o funcionamento pessoal e social de seus portadores. O TDAH apresenta múltiplos fatores associados a sua fisiopatologia, sem haver, até então, uma causa exclusiva. Objetivos: o objetivo deste trabalho é analisar as interações gene-ambiente e mecanismos neurobiológicos envolvidos na etiologia do TDAH, a fim de contribuir para uma melhor compreensão do transtorno. Metodologia: foram realizadas pesquisas em bases de dados como MedLine, Pubmed e Scielo, com o uso dos descritores; Attention Deficit Hyperactivity Disorder; ADHD; neurobiology of ADHD. Resultados: os estudos revisados destacaram alterações morfofuncionais de regiões cerebrais específicas, quando em associação ao TDAH. Além disso, a combinação de diferentes fatores genéticos e ambientais podem influenciar no desenvolvimento do transtorno. Conclusões: a compreensão aprofundada da neurobiologia do TDAH é essencial para o desenvolvimento de intervenções mais eficazes, a fim de melhorar a qualidade de vida dos portadores do transtorno.
- 21 October 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (4) , 4264-4273
Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization
Patients with COVID-19 can develop excessive inflammation in the brain and consequent neurological complications. The aim of this study was to evaluate the inflammatory, endothelial and brain injury markers in hospitalized COVID-19 patients and compare those with or without neurological symptoms. A total of 30 intensive care unit (ICU) COVID-19 patients were allocated into COVID-19 (without neurological symptoms) or neuro-COVID-19 (with neurological symptoms) groups. Patients with respiratory infection symptoms but negative for COVID-19 were included as a control group. Peripheral blood samples were collected at hospital admission (T1) (controls and ICU patients) and during hospitalization (T2: last 72 h before hospital discharge or in-hospital death) (ICU COVID-19 patients) to analyze inflammatory markers. Higher ICAM-1, CCL26 and VEGF at T1 were identified in both COVID-19 groups compared with control. Neuro-COVID-19 patients presented lower systemic BDNF levels compared with the control group and increased S100B compared with the control and COVID-19 groups. BDNF levels in survivors were lower in the neuro-COVID-19 group compared to the COVID-19 group, while S100B were higher, regardless of the outcome. In addition, all COVID‐19 patients presented increased ICAM-1 and CCL26 levels over the hospitalization period (T2 > T1). Furthermore, S100B, ICAM-1, CCL26 and VEGF levels increased in relation to T1 in neuro-COVID-19 patients, with S100B and CCL26 being significantly higher in relation to the COVID-19 group. In conclusion, high levels of brain injury biomarkers were found in patients with neuro-COVID-19, indicating neuroinflammatory and consequent brain injury in the last 72 h of hospitalization.
- 21 October 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (4) , 4264-4273
Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization
Patients with COVID-19 can develop excessive inflammation in the brain and consequent neurological complications. The aim of this study was to evaluate the inflammatory, endothelial and brain injury markers in hospitalized COVID-19 patients and compare those with or without neurological symptoms. A total of 30 intensive care unit (ICU) COVID-19 patients were allocated into COVID-19 (without neurological symptoms) or neuro-COVID-19 (with neurological symptoms) groups. Patients with respiratory infection symptoms but negative for COVID-19 were included as a control group. Peripheral blood samples were collected at hospital admission (T1) (controls and ICU patients) and during hospitalization (T2: last 72 h before hospital discharge or in-hospital death) (ICU COVID-19 patients) to analyze inflammatory markers. Higher ICAM-1, CCL26 and VEGF at T1 were identified in both COVID-19 groups compared with control. Neuro-COVID-19 patients presented lower systemic BDNF levels compared with the control group and increased S100B compared with the control and COVID-19 groups. BDNF levels in survivors were lower in the neuro-COVID-19 group compared to the COVID-19 group, while S100B were higher, regardless of the outcome. In addition, all COVID‐19 patients presented increased ICAM-1 and CCL26 levels over the hospitalization period (T2 > T1). Furthermore, S100B, ICAM-1, CCL26 and VEGF levels increased in relation to T1 in neuro-COVID-19 patients, with S100B and CCL26 being significantly higher in relation to the COVID-19 group. In conclusion, high levels of brain injury biomarkers were found in patients with neuro-COVID-19, indicating neuroinflammatory and consequent brain injury in the last 72 h of hospitalization.
- Open Access
- 20 May 2024
- Published by Disciplinarum Scientia: Serie Ciencias Naturais e Tecnologicas in Disciplinarum Scientia - Ciências Naturais e Tecnológicas
- Vol. 25 (2) , 93-109
Mini revisão: neuroproteção de nanomateriais contendendo antioxidantes em modelos de isquemia cerebral
O acidente vascular cerebral, especialmente o isquêmico, é um grande problema de saúde pública mundial, porém, atualmente, existem poucos tratamentos disponíveis para essa doença. Os antioxidantes têm sido alvo de buscas por novas terapias, mas muitas de suas propriedades dificultam o uso farmacológico, como baixa biodisponibilidade e autoxidação. A nanotecnologia pode ser usada para melhorar essas propriedades e levar os compostos ao cérebro. Assim, esta revisão integrativa analisou estudos que utilizaram nanoestruturas contendo ativos com propriedades antioxidantes com efeitos protetores contra os danos decorrentes da isquemia cerebral. Os resultados indicaram que todos os ativos nanoestruturados utilizados apresentaram eficiente ação neuroprotetora e potencial antioxidante, tanto in vitro quanto in vivo, o que foi demonstrado pelo aumento dos níveis de atividades de enzimas antioxidantes, diminuição da peroxidação lipídica e redução da apoptose celular e infarto tecidual. Vários estudos também mostraram melhora neurocomportamental adicional em roedores. Portanto, a nanoestruturação de compostos ativos com propriedades antioxidantes pode ser um bom adjuvante no tratamento do acidente vascular cerebral isquêmico, pois pode efetivamente aumentar a biodisponibilidade desses compostos e fornecer melhor acesso à região danificada para induzir proteção ao cérebro.
- 20 May 2024
- Published by Disciplinarum Scientia: Serie Ciencias Naturais e Tecnologicas in Disciplinarum Scientia - Ciências Naturais e Tecnológicas
- Vol. 25 (2) , 93-109
Open AccessMini revisão: neuroproteção de nanomateriais contendendo antioxidantes em modelos de isquemia cerebral
O acidente vascular cerebral, especialmente o isquêmico, é um grande problema de saúde pública mundial, porém, atualmente, existem poucos tratamentos disponíveis para essa doença. Os antioxidantes têm sido alvo de buscas por novas terapias, mas muitas de suas propriedades dificultam o uso farmacológico, como baixa biodisponibilidade e autoxidação. A nanotecnologia pode ser usada para melhorar essas propriedades e levar os compostos ao cérebro. Assim, esta revisão integrativa analisou estudos que utilizaram nanoestruturas contendo ativos com propriedades antioxidantes com efeitos protetores contra os danos decorrentes da isquemia cerebral. Os resultados indicaram que todos os ativos nanoestruturados utilizados apresentaram eficiente ação neuroprotetora e potencial antioxidante, tanto in vitro quanto in vivo, o que foi demonstrado pelo aumento dos níveis de atividades de enzimas antioxidantes, diminuição da peroxidação lipídica e redução da apoptose celular e infarto tecidual. Vários estudos também mostraram melhora neurocomportamental adicional em roedores. Portanto, a nanoestruturação de compostos ativos com propriedades antioxidantes pode ser um bom adjuvante no tratamento do acidente vascular cerebral isquêmico, pois pode efetivamente aumentar a biodisponibilidade desses compostos e fornecer melhor acesso à região danificada para induzir proteção ao cérebro.
- 4 March 2024
- Published by Taylor & Francis in Journal of Ethnicity in Substance Abuse
- Vol. 24 (4) , 1127-1141
Self-reported neurostimulant use among university students in Santa Maria, Rio Grande do Sul, Brazil
University students frequently resort to psychostimulants to enhance their physical and mental performance and manage academic pressures. However, these substances can lead to dependence and other undesired symptoms, and little empirical data are available for relevant stakeholders, raising significant concerns in health care. Therefore, this study aims to characterize neurostimulant use among university students in Rio Grande do Sul, Brazil. We collected from 880 students' data using anonymous self-administration. The questionnaire included consumption patterns of caffeine, nicotine, ecstasy, methamphetamine, "merla" (coca base), methylphenidate, cocaine, crack, and ketamine. Additionally, participants shared information on demographic and socioeconomic factors. Use of at least one neurostimulant was reported by89.2% of the participants. Among nonusers, the most frequently cited reason was "previous information about harmful effects of these drugs." Caffeine, followed by nicotine, ecstasy, and methylphenidate were the most consumed substances, with main reasons being "improving academic performance" and "recreation." Women more often consumed caffeine (72.7%), while other psychostimulants were more consumed by men (42.2%) and individuals of other genders (0.5%). Students who consumed other substances had higher family incomes than that of families of caffeine users. In addition, 60.4% of caffeine users resided with family members, whereas 63.3% of users of other substances did not. Our findings can offer essential data on the reasons and symptoms associated with the use of neurostimulants among university students. This information could aid in raising awareness among students, universities, and health-care agencies about this often-neglected subject.
- 4 March 2024
- Published by Taylor & Francis in Journal of Ethnicity in Substance Abuse
- Vol. 24 (4) , 1127-1141
Self-reported neurostimulant use among university students in Santa Maria, Rio Grande do Sul, Brazil
University students frequently resort to psychostimulants to enhance their physical and mental performance and manage academic pressures. However, these substances can lead to dependence and other undesired symptoms, and little empirical data are available for relevant stakeholders, raising significant concerns in health care. Therefore, this study aims to characterize neurostimulant use among university students in Rio Grande do Sul, Brazil. We collected from 880 students' data using anonymous self-administration. The questionnaire included consumption patterns of caffeine, nicotine, ecstasy, methamphetamine, "merla" (coca base), methylphenidate, cocaine, crack, and ketamine. Additionally, participants shared information on demographic and socioeconomic factors. Use of at least one neurostimulant was reported by89.2% of the participants. Among nonusers, the most frequently cited reason was "previous information about harmful effects of these drugs." Caffeine, followed by nicotine, ecstasy, and methylphenidate were the most consumed substances, with main reasons being "improving academic performance" and "recreation." Women more often consumed caffeine (72.7%), while other psychostimulants were more consumed by men (42.2%) and individuals of other genders (0.5%). Students who consumed other substances had higher family incomes than that of families of caffeine users. In addition, 60.4% of caffeine users resided with family members, whereas 63.3% of users of other substances did not. Our findings can offer essential data on the reasons and symptoms associated with the use of neurostimulants among university students. This information could aid in raising awareness among students, universities, and health-care agencies about this often-neglected subject.
- 16 January 2024
- Published by SAGE Publications in Armed Forces & Society
- Vol. 51 (3) , 979-995
Workplace Stress in Military Women During the COVID-19 Pandemic in Brazil: A Research Note
This study evaluated the prevalence of burnout syndrome symptoms and related factors in Brazilian military women during COVID-19 pandemic. The symptoms are a combination of physical tiredness, emotional exhaustion, and cognitive depletion, which are related to the job activity and result in mental disconnection with work and reduced professional achievement. It is a cross-sectional study on the frequency of burnout syndrome in military women in which individual questionnaires were delivered via e-mail and returned by the same form. The results revealed that 44.5% of the 164 military women were affected by burnout syndrome. The organizational environment, work overload, control over tasks, and some individual conditions can be highlighted among the factors for developing symptoms. The occurrence of stress symptoms among Brazilian military women was probably due to the constant exposure to stress in their job. The implications of women’s military service on their performance to work during the pandemic are discussed.
- 16 January 2024
- Published by SAGE Publications in Armed Forces & Society
- Vol. 51 (3) , 979-995
Workplace Stress in Military Women During the COVID-19 Pandemic in Brazil: A Research Note
This study evaluated the prevalence of burnout syndrome symptoms and related factors in Brazilian military women during COVID-19 pandemic. The symptoms are a combination of physical tiredness, emotional exhaustion, and cognitive depletion, which are related to the job activity and result in mental disconnection with work and reduced professional achievement. It is a cross-sectional study on the frequency of burnout syndrome in military women in which individual questionnaires were delivered via e-mail and returned by the same form. The results revealed that 44.5% of the 164 military women were affected by burnout syndrome. The organizational environment, work overload, control over tasks, and some individual conditions can be highlighted among the factors for developing symptoms. The occurrence of stress symptoms among Brazilian military women was probably due to the constant exposure to stress in their job. The implications of women’s military service on their performance to work during the pandemic are discussed.
- Open Access
- 18 September 2023
- Published by Springer Nature in Molecular and Cellular Pediatrics
- Vol. 10 (1) , 1-13
What do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature
Objective: Scientific scrutiny has proved the safety and benefits of caffeine to treat apnoea of prematurity (AOP). However, there is no consensus on the effects of this treatment on sleep, especially considering the key role of adenosine and early brain development for sleep maturation. We systematically reviewed studies with sleep as a primary and/or secondary outcome or any mention of sleep parameters in the context of caffeine treatment for AOP. Methods: We performed a systematic search of PubMed, Web of Science and the Virtual Health Library from inception to 7 September 2022 to identify studies investigating the short- and long-term effects of caffeine to treat AOP on sleep parameters. We used the PIC strategy considering preterm infants as the Population, caffeine for apnoea as the Intervention and no or other intervention other than caffeine as the Comparison. We registered the protocol on PROSPERO (CRD42021282536). Results: Of 4019 studies, we deemed 20, including randomised controlled trials and follow-up and observational studies, to be eligible for our systematic review. The analysed sleep parameters, the evaluation phase and the instruments for sleep assessment varied considerably among the studies. The main findings can be summarised as follows: (i) most of the eligible studies in this systematic review indicate that caffeine used to treat AOP seems to have no effect on key sleep parameters and (ii) the effects on sleep when caffeine is administered earlier, at higher doses or for longer periods than the most common protocol have not been investigated. There is a possible correlation between the caffeine concentration and period of exposure and negative sleep quality, but the sleep assessment protocols used in the included studies did not have high-quality standards and could not provide good evidence. Conclusions and implications: Sleep quality is an important determinant of health, and better investments in research with adequate sleep assessment tools are necessary to guarantee the ideal management of children who were born preterm.
- 18 September 2023
- Published by Springer Nature in Molecular and Cellular Pediatrics
- Vol. 10 (1) , 1-13
Open AccessWhat do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature
Objective: Scientific scrutiny has proved the safety and benefits of caffeine to treat apnoea of prematurity (AOP). However, there is no consensus on the effects of this treatment on sleep, especially considering the key role of adenosine and early brain development for sleep maturation. We systematically reviewed studies with sleep as a primary and/or secondary outcome or any mention of sleep parameters in the context of caffeine treatment for AOP. Methods: We performed a systematic search of PubMed, Web of Science and the Virtual Health Library from inception to 7 September 2022 to identify studies investigating the short- and long-term effects of caffeine to treat AOP on sleep parameters. We used the PIC strategy considering preterm infants as the Population, caffeine for apnoea as the Intervention and no or other intervention other than caffeine as the Comparison. We registered the protocol on PROSPERO (CRD42021282536). Results: Of 4019 studies, we deemed 20, including randomised controlled trials and follow-up and observational studies, to be eligible for our systematic review. The analysed sleep parameters, the evaluation phase and the instruments for sleep assessment varied considerably among the studies. The main findings can be summarised as follows: (i) most of the eligible studies in this systematic review indicate that caffeine used to treat AOP seems to have no effect on key sleep parameters and (ii) the effects on sleep when caffeine is administered earlier, at higher doses or for longer periods than the most common protocol have not been investigated. There is a possible correlation between the caffeine concentration and period of exposure and negative sleep quality, but the sleep assessment protocols used in the included studies did not have high-quality standards and could not provide good evidence. Conclusions and implications: Sleep quality is an important determinant of health, and better investments in research with adequate sleep assessment tools are necessary to guarantee the ideal management of children who were born preterm.